4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-25-004907
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Mendelsohn Michael Director | 2025-06-17 | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $119,750 | 25,000 | D |
Loading xslF345X05/primarydocument.xml…